Cyclosporine-associated reduction in systolic myocardial function in the rat.

[1]  M. Kaltenbach,et al.  Isolated rat cardiomyocytes as an experimental model for studying acute cardiotoxicity of cyclosporin A. , 1990, International journal of cardiology.

[2]  N. Vaziri,et al.  Effects of cyclosporine on magnesium metabolism in rats. , 1989, The Journal of laboratory and clinical medicine.

[3]  J. Brockmöller,et al.  Neurotoxicity caused by a high cyclosporine metabolite level. , 1989, Transplantation.

[4]  R. Safirstein,et al.  Glomerular hemodynamics in cyclosporine nephrotoxicity following uninephrectomy. , 1989, Kidney international.

[5]  M. Seelig.  Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations--magnesium and chloride loss in refractory potassium repletion. , 1989, The American journal of cardiology.

[6]  K. Skorecki,et al.  Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells. , 1989, Transplantation.

[7]  W. Nayler,et al.  Immunosuppressive and cardiotoxic effects of cyclosporine in CBA mice. , 1989, Transplantation.

[8]  N. Wong,et al.  Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats. , 1988, Clinical science.

[9]  L. Truong,et al.  CHRONIC CYCLOSPORINE NEPHROTOXICITY A RODENT MODEL , 1988, Transplantation.

[10]  M. Verani,et al.  Systolic and diastolic ventricular performance at rest and during exercise in heart transplant recipients. , 1988, The Journal of heart transplantation.

[11]  W. Nayler,et al.  Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts. , 1987, Transplantation proceedings.

[12]  J. Dedman,et al.  Does the binding of cyclosporine to calmodulin result in immunosuppression? , 1986, Science.

[13]  P. Miach,et al.  Cyclosporin A in organ transplantation , 1986, The Medical journal of Australia.

[14]  J. Ménard,et al.  Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. , 1985, The American journal of cardiology.

[15]  C. Nicchitta,et al.  Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. , 1985, The Journal of biological chemistry.

[16]  B. Langer,et al.  PHARMACOKINETIC PROFILES OF CYCLOSPORINE IN RATS: INFLUENCE OF ROUTE OF ADMINISTRATION AND DOSAGE , 1985, Transplantation.

[17]  J. Nims,et al.  PROFOUND HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING ASSOCIATED WITH THE USE OF CYCLOSPORINE FOR MARROW TRANSPLANTATION , 1985, Transplantation.

[18]  B. Altura,et al.  New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. , 1985, Magnesium.

[19]  R. Schindler.  Ciclosporin in Autoimmune Diseases , 1985, Springer Berlin Heidelberg.

[20]  D. Allen,et al.  Characterization of oscillations of intracellular calcium concentration in ferret ventricular muscle. , 1984, The Journal of physiology.

[21]  S. Massry.  Parathyroid Hormone and Uremic Myocardiopathy1 , 1984 .

[22]  M. Rambausek,et al.  Cardiac function in experimental uremia. , 1983, Kidney international. Supplement.

[23]  J. McNeill,et al.  Positive inotropic responses in cardiac muscles: influence of stimulation frequency and species. , 1982, Canadian journal of physiology and pharmacology.

[24]  S. Massry,et al.  Effect of parathyroid hormone on rat heart cells. , 1981, The Journal of clinical investigation.

[25]  F. Kersting,et al.  Uremic cardiomyopathy: studies on cardiac function in the guinea pig. , 1978, Clinical nephrology.

[26]  T. Nivatpumin,et al.  Effects of Moderate Uremia on Cardiac Contractile Responses 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[27]  L. Delfosse,et al.  Automated analysis of hydroxyproline in urine. , 1975, Indian journal of biochemistry & biophysics.

[28]  T. Nivatpumin,et al.  Increased cardiac contractility in acute uremia: interrelationships with hypertension. , 1975, The American journal of physiology.

[29]  N. Blumenkrantz,et al.  An automated procedure for quantitative determination of hydroxyproline. , 1974, Clinical biochemistry.

[30]  J. Scheuer,et al.  The effects of uremic compounds on cardiac function and metabolism. , 1973, Journal of molecular and cellular cardiology.